Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder.

Abstract

BACKGROUND Despite evidence suggesting that the majority of patients with hepatitis C virus (HCV) have psychiatric and substance use disorders, patients with these comorbidities have historically been excluded from antiviral therapy for HCV. OBJECTIVE The authors compared antiviral completion and sustained virologic response (SVR) rates between hepatitis C (HCV) patients with versus those without preexisting major depressive disorder (MDD). METHOD The authors performed a chart review of HCV patients (30 with MDD and 25 control subjects) who attended an optional HCV education class and signed informed consent allowing collection of clinical data. RESULTS The MDD group had completion and SVR rates similar to those of control subjects. Neuropsychiatric side effects and reasons for discontinuation of treatment were not different between groups. CONCLUSION Patients with MDD can be safely and effectively treated with antiviral therapy.

DOI: 10.1176/appi.psy.50.5.500
010203020102011201220132014201520162017
Citations per Year

52 Citations

Semantic Scholar estimates that this publication has 52 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Hauser2009AntiviralCR, title={Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder.}, author={Peter V. Hauser and Benjamin J. Morasco and Alex M Linke and Dannell Bjornson and Samantha Ruimy and Annette M. Matthews and A Hind Rifai and David W Indest and Jennifer M. Loftis}, journal={Psychosomatics}, year={2009}, volume={50 5}, pages={500-5} }